IBDEI181 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20762,0)
 ;;=D86.86^^84^939^39
 ;;^UTILITY(U,$J,358.3,20762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20762,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,20762,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,20762,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,20763,0)
 ;;=D86.87^^84^939^43
 ;;^UTILITY(U,$J,358.3,20763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20763,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,20763,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,20763,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,20764,0)
 ;;=D86.3^^84^939^49
 ;;^UTILITY(U,$J,358.3,20764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20764,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,20764,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,20764,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,20765,0)
 ;;=D86.81^^84^939^41
 ;;^UTILITY(U,$J,358.3,20765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20765,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,20765,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,20765,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,20766,0)
 ;;=D86.82^^84^939^50
 ;;^UTILITY(U,$J,358.3,20766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20766,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,20766,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,20766,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,20767,0)
 ;;=D86.84^^84^939^44
 ;;^UTILITY(U,$J,358.3,20767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20767,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,20767,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,20767,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,20768,0)
 ;;=D86.85^^84^939^42
 ;;^UTILITY(U,$J,358.3,20768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20768,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,20768,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,20768,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,20769,0)
 ;;=D86.83^^84^939^40
 ;;^UTILITY(U,$J,358.3,20769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20769,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,20769,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,20769,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,20770,0)
 ;;=D84.1^^84^939^16
 ;;^UTILITY(U,$J,358.3,20770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20770,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,20770,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,20770,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,20771,0)
 ;;=D81.810^^84^939^5
 ;;^UTILITY(U,$J,358.3,20771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20771,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,20771,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,20771,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,20772,0)
 ;;=E88.01^^84^939^2
 ;;^UTILITY(U,$J,358.3,20772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20772,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,20772,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,20772,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,20773,0)
 ;;=J09.X1^^84^939^25
 ;;^UTILITY(U,$J,358.3,20773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20773,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,20773,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,20773,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,20774,0)
 ;;=J09.X2^^84^939^26
 ;;^UTILITY(U,$J,358.3,20774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20774,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,20774,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,20774,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,20775,0)
 ;;=J09.X3^^84^939^27
